Skip to main content
Top
Published in: Journal of NeuroVirology 5/2019

01-10-2019 | Stroke

Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm

Authors: Lucette A. Cysique, Bruce J. Brew

Published in: Journal of NeuroVirology | Issue 5/2019

Login to get access

Abstract

In this review, we propose that vascular cognitive impairment (VCI), with relevance for the global HIV population, is fundamentally and clinically linked to the persistence of mild forms of HIV-associated neurocognitive disorders (HAND) in ageing people living with HIV infection (PLWH). After placing our review within the context of the general literature on HIV and ageing, we review non-VCI risks for dementia in ageing PLWH. We then present the recently updated VCI nomenclature and show that the neuropsychological and neuroimaging phenotypes of VCI and HAND are largely overlapping, suggesting that further research is needed to accurately distinguish them. We further link VCI and HAND at the mechanistic level by advancing the innovative proposal that the neuro-vascular unit (NVU) may represent the primary target of HIV-related brain injury in treated HIV infection. To this, we add the fundamental impact of mild and major VCI on the NVU. Importantly, we show that the potential contribution of vascular damage to overall brain damage in ageing PLWH is probably much higher than currently estimated because of methodological limitations, and because this research is only emerging. Finally, because all VCI risk factors are more prevalent, premature, and sometimes accelerated in the HIV population at large, we conclude that the probable total burden of VCI in the global HIV population is higher than in the general population and would need to be compared to chronic conditions such as type I diabetes and multiple sclerosis to account for the disease chronicity and lifelong treatment effects. Therefore, this review is also a call to action. Indeed, it is fully established that this amount of VCI burden is a major risk factor for dementia at aged 60+.
Literature
go back to reference Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, Rimland D, Rodriguez-Barradas MC, Dubrow R, Park LS, Skanderson M, Shiels MS, Gange SJ, Gebo KA, Justice AC (2015) Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 60:627–638PubMedCrossRef Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, Rimland D, Rodriguez-Barradas MC, Dubrow R, Park LS, Skanderson M, Shiels MS, Gange SJ, Gebo KA, Justice AC (2015) Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 60:627–638PubMedCrossRef
go back to reference Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799PubMedCrossRef Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799PubMedCrossRef
go back to reference Appay V, Sauce D (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214:231–241PubMedCrossRef Appay V, Sauce D (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214:231–241PubMedCrossRef
go back to reference Atluri VS, Hidalgo M, Samikkannu T, Kurapati KR, Jayant RD, Sagar V, Nair MP (2015) Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 9:212PubMedPubMedCentralCrossRef Atluri VS, Hidalgo M, Samikkannu T, Kurapati KR, Jayant RD, Sagar V, Nair MP (2015) Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 9:212PubMedPubMedCentralCrossRef
go back to reference Bachani M, Sacktor N, McArthur JC, Nath A, Rumbaugh J (2013) Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J Neuro-Oncol 19:82–88 Bachani M, Sacktor N, McArthur JC, Nath A, Rumbaugh J (2013) Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J Neuro-Oncol 19:82–88
go back to reference Benjamin LA, Bryer A, Lucas S, Stanley A, Allain TJ, Joekes E, Emsley H, Turnbull I, Downey C, Toh CH, Brown K, Brown D, Ison C, Smith C, Corbett EL, Nath A, Heyderman RS, Connor MD, Solomon T (2016) Arterial ischemic stroke in HIV: defining and classifying etiology for research studies. Neurol Neuroimmunol Neuroinflamm 3:e254PubMedPubMedCentralCrossRef Benjamin LA, Bryer A, Lucas S, Stanley A, Allain TJ, Joekes E, Emsley H, Turnbull I, Downey C, Toh CH, Brown K, Brown D, Ison C, Smith C, Corbett EL, Nath A, Heyderman RS, Connor MD, Solomon T (2016) Arterial ischemic stroke in HIV: defining and classifying etiology for research studies. Neurol Neuroimmunol Neuroinflamm 3:e254PubMedPubMedCentralCrossRef
go back to reference Biesbroek JM, Weaver NA, Biessels GJ (2017) Lesion location and cognitive impact of cerebral small vessel disease. Clin Sci (Lond) 131:715–728CrossRef Biesbroek JM, Weaver NA, Biessels GJ (2017) Lesion location and cognitive impact of cerebral small vessel disease. Clin Sci (Lond) 131:715–728CrossRef
go back to reference Bijker R, Choi JY, Ditangco R, Kiertiburanakul S, Lee MP, Siwamogsatham S, Pujari S, Ross J, Wong C, Wong WW, Yunihastuti E, Law M (2017) Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region. Open AIDS J 11:52–66PubMedPubMedCentralCrossRef Bijker R, Choi JY, Ditangco R, Kiertiburanakul S, Lee MP, Siwamogsatham S, Pujari S, Ross J, Wong C, Wong WW, Yunihastuti E, Law M (2017) Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region. Open AIDS J 11:52–66PubMedPubMedCentralCrossRef
go back to reference Blokhuis C, Mutsaerts HJ, Cohen S, Scherpbier HJ, Caan MW, Majoie CB, Kuijpers TW, Reiss P, Wit FW, Pajkrt D (2017) Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children. Medicine (Baltimore) 96:e5891CrossRef Blokhuis C, Mutsaerts HJ, Cohen S, Scherpbier HJ, Caan MW, Majoie CB, Kuijpers TW, Reiss P, Wit FW, Pajkrt D (2017) Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children. Medicine (Baltimore) 96:e5891CrossRef
go back to reference Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998) Variable progression of HIV-associated dementia. Neurology 50:1814–1820PubMedCrossRef Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998) Variable progression of HIV-associated dementia. Neurology 50:1814–1820PubMedCrossRef
go back to reference Brew BJ (2016) Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment? AIDS 30:2379–2380PubMedCrossRef Brew BJ (2016) Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment? AIDS 30:2379–2380PubMedCrossRef
go back to reference Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2009) Neurodegeneration and ageing in the HAART era. J NeuroImmune Pharmacol 4:163–174PubMedCrossRef Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2009) Neurodegeneration and ageing in the HAART era. J NeuroImmune Pharmacol 4:163–174PubMedCrossRef
go back to reference Brunt SJ, Cysique LA, Lee S, Burrows S, Brew BJ, Price P (2016) Short communication: do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy? AIDS Res Hum Retrovir 32:567–572PubMedCrossRef Brunt SJ, Cysique LA, Lee S, Burrows S, Brew BJ, Price P (2016) Short communication: do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy? AIDS Res Hum Retrovir 32:567–572PubMedCrossRef
go back to reference Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA Jr, Willis M, Yancy CW (2017) Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation 136:e393–e423PubMedCrossRef Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA Jr, Willis M, Yancy CW (2017) Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation 136:e393–e423PubMedCrossRef
go back to reference Chow FC, Price RW, Hsue PY, Kim AS (2017) Greater risk of stroke of undetermined etiology in a contemporary HIV-infected cohort compared with uninfected individuals. J Stroke Cerebrovasc Dis 26:1154–1160PubMedPubMedCentralCrossRef Chow FC, Price RW, Hsue PY, Kim AS (2017) Greater risk of stroke of undetermined etiology in a contemporary HIV-infected cohort compared with uninfected individuals. J Stroke Cerebrovasc Dis 26:1154–1160PubMedPubMedCentralCrossRef
go back to reference Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA (2012) Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr 60:351–358PubMedPubMedCentralCrossRef Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA (2012) Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr 60:351–358PubMedPubMedCentralCrossRef
go back to reference Christopher B, Nadine RC, Mohamad AH, Ahmed K, Subodh V, Mohammed AO (2018) Peripheral artery disease among indigenous Canadians: what do we know? Can J Surg 61:305–310 Christopher B, Nadine RC, Mohamad AH, Ahmed K, Subodh V, Mohammed AO (2018) Peripheral artery disease among indigenous Canadians: what do we know? Can J Surg 61:305–310
go back to reference Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM, Rosen HJ, Kramer JH, Allen IE, Valcour VG (2017) Progressive brain atrophy despite persistent viral suppression in HIV patients older than 60 years. J Acquir Immune Defic Syndr 76:289–297PubMedPubMedCentralCrossRef Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM, Rosen HJ, Kramer JH, Allen IE, Valcour VG (2017) Progressive brain atrophy despite persistent viral suppression in HIV patients older than 60 years. J Acquir Immune Defic Syndr 76:289–297PubMedPubMedCentralCrossRef
go back to reference Cody SL, Vance DE (2016) The neurobiology of HIV and its impact on cognitive reserve: a review of cognitive interventions for an aging population. Neurobiol Dis 92:144–156PubMedCrossRef Cody SL, Vance DE (2016) The neurobiology of HIV and its impact on cognitive reserve: a review of cognitive interventions for an aging population. Neurobiol Dis 92:144–156PubMedCrossRef
go back to reference Cole JH, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ (2017) Increased brain-predicted aging in treated HIV disease. Neurology 88:1349–1357PubMedPubMedCentralCrossRef Cole JH, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ (2017) Increased brain-predicted aging in treated HIV disease. Neurology 88:1349–1357PubMedPubMedCentralCrossRef
go back to reference Cummins D, Waters D, Aggar C, Crawford D, Fethney J, O'Connor C (2018) Voices from Australia—concerns about HIV associated neurocognitive disorder. AIDS Care 30:609–617PubMedCrossRef Cummins D, Waters D, Aggar C, Crawford D, Fethney J, O'Connor C (2018) Voices from Australia—concerns about HIV associated neurocognitive disorder. AIDS Care 30:609–617PubMedCrossRef
go back to reference Cysique LA, Bain MP, Brew BJ, Murray JM (2011) The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future. Sex Health 8:541–550PubMedCrossRef Cysique LA, Bain MP, Brew BJ, Murray JM (2011) The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future. Sex Health 8:541–550PubMedCrossRef
go back to reference Cysique LA, Brew BJ (2009) Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev 19:169–185PubMedCrossRef Cysique LA, Brew BJ (2009) Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev 19:169–185PubMedCrossRef
go back to reference Cysique LA, Brew BJ (2014) The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years’ findings. Curr Opin HIV AIDS 9:355–364PubMedCrossRef Cysique LA, Brew BJ (2014) The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years’ findings. Curr Opin HIV AIDS 9:355–364PubMedCrossRef
go back to reference Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ (2014) HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neuro-Oncol 20:258–268 Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ (2014) HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neuro-Oncol 20:258–268
go back to reference Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, Brew BJ, Rae C (2013) HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS One 8:e61738PubMedPubMedCentralCrossRef Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, Brew BJ, Rae C (2013) HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS One 8:e61738PubMedPubMedCentralCrossRef
go back to reference Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, Brew BJ, Henry RG, Rae C (2017) White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration. J Neuro-Oncol 23:539–547 Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, Brew BJ, Henry RG, Rae C (2017) White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration. J Neuro-Oncol 23:539–547
go back to reference Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW (2014) Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS 28:2251–2258PubMedCrossRef Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW (2014) Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS 28:2251–2258PubMedCrossRef
go back to reference Dawood H, Hassan-Moosa R, Zuma NY, Naidoo K (2018) Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa. BMC Infect Dis 18:168PubMedPubMedCentralCrossRef Dawood H, Hassan-Moosa R, Zuma NY, Naidoo K (2018) Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa. BMC Infect Dis 18:168PubMedPubMedCentralCrossRef
go back to reference de Roos A, van der Grond J, Mitchell G, Westenberg J (2017) Magnetic resonance imaging of cardiovascular function and the brain: is dementia a cardiovascular-driven disease? Circulation 135:2178–2195PubMedPubMedCentralCrossRef de Roos A, van der Grond J, Mitchell G, Westenberg J (2017) Magnetic resonance imaging of cardiovascular function and the brain: is dementia a cardiovascular-driven disease? Circulation 135:2178–2195PubMedPubMedCentralCrossRef
go back to reference Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, Brayne C, Dartigues JF, Engedal K, Kivipelto M, Ritchie K, Starr JM, Yaffe K, Irving K, Verhey FR, Kohler S (2015) Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30:234–246PubMedCrossRef Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, Brayne C, Dartigues JF, Engedal K, Kivipelto M, Ritchie K, Starr JM, Yaffe K, Irving K, Verhey FR, Kohler S (2015) Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30:234–246PubMedCrossRef
go back to reference Durand M, Sheehy O, Baril JG, LeLorier J, Tremblay CL (2013) Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study. J Stroke Cerebrovasc Dis 22:e34–e41PubMedCrossRef Durand M, Sheehy O, Baril JG, LeLorier J, Tremblay CL (2013) Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study. J Stroke Cerebrovasc Dis 22:e34–e41PubMedCrossRef
go back to reference Ford E, Greenslade N, Paudyal P, Bremner S, Smith HE, Banerjee S, Sadhwani S, Rooney P, Oliver S, Cassell J (2018) Predicting dementia from primary care records: a systematic review and meta-analysis. PLoS One 13:e0194735PubMedPubMedCentralCrossRef Ford E, Greenslade N, Paudyal P, Bremner S, Smith HE, Banerjee S, Sadhwani S, Rooney P, Oliver S, Cassell J (2018) Predicting dementia from primary care records: a systematic review and meta-analysis. PLoS One 13:e0194735PubMedPubMedCentralCrossRef
go back to reference Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17:491–501PubMedCrossRef Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17:491–501PubMedCrossRef
go back to reference Fulop T, Witkowski JM, Bourgade K, Khalil A, Zerif E, Larbi A, Hirokawa K, Pawelec G, Bocti C, Lacombe G, Dupuis G, Frost EH (2018) Can an infection hypothesis explain the beta amyloid hypothesis of Alzheimer’s disease? Front Aging Neurosci 10:224PubMedPubMedCentralCrossRef Fulop T, Witkowski JM, Bourgade K, Khalil A, Zerif E, Larbi A, Hirokawa K, Pawelec G, Bocti C, Lacombe G, Dupuis G, Frost EH (2018) Can an infection hypothesis explain the beta amyloid hypothesis of Alzheimer’s disease? Front Aging Neurosci 10:224PubMedPubMedCentralCrossRef
go back to reference Gates TM, Cysique LA (2016) The chronicity of HIV infection should drive the research strategy of NeuroHIV treatment studies: a critical review. CNS Drugs 30:53–69PubMedPubMedCentralCrossRef Gates TM, Cysique LA (2016) The chronicity of HIV infection should drive the research strategy of NeuroHIV treatment studies: a critical review. CNS Drugs 30:53–69PubMedPubMedCentralCrossRef
go back to reference GBD 2015 HIV Collaborators (2016) Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV 3:e361–e387CrossRef GBD 2015 HIV Collaborators (2016) Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV 3:e361–e387CrossRef
go back to reference Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV/AIDS Rep 12:272–279PubMedPubMedCentralCrossRef Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV/AIDS Rep 12:272–279PubMedPubMedCentralCrossRef
go back to reference Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA, Morgello S (2012) The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 7:e46178PubMedPubMedCentralCrossRef Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA, Morgello S (2012) The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 7:e46178PubMedPubMedCentralCrossRef
go back to reference Giuliano M, Pirillo MF, Liotta G, Andreotti M, Jere H, Sagno JB, Ciccacci F, Amici R, Marazzi MC, Vella S, Palombi L, Mancinelli S (2017) High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women. J Clin Virol 96:17–19PubMedCrossRef Giuliano M, Pirillo MF, Liotta G, Andreotti M, Jere H, Sagno JB, Ciccacci F, Amici R, Marazzi MC, Vella S, Palombi L, Mancinelli S (2017) High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women. J Clin Virol 96:17–19PubMedCrossRef
go back to reference Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755–762PubMedCrossRef Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755–762PubMedCrossRef
go back to reference Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC (2017) Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study. Lancet HIV 4:e411–e422PubMedPubMedCentralCrossRef Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC (2017) Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study. Lancet HIV 4:e411–e422PubMedPubMedCentralCrossRef
go back to reference Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2672–2713PubMedPubMedCentralCrossRef Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2672–2713PubMedPubMedCentralCrossRef
go back to reference Gott C, Gates T, Dermody N, Brew BJ, Cysique LA (2017) Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS One 12:e0171887PubMedPubMedCentralCrossRef Gott C, Gates T, Dermody N, Brew BJ, Cysique LA (2017) Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS One 12:e0171887PubMedPubMedCentralCrossRef
go back to reference Grant I, Franklin DR Jr, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82:2055–2062PubMedPubMedCentralCrossRef Grant I, Franklin DR Jr, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82:2055–2062PubMedPubMedCentralCrossRef
go back to reference Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53:1120–1126CrossRefPubMed Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53:1120–1126CrossRefPubMed
go back to reference Guaraldi G, Palella FJ Jr (2017) Clinical implications of aging with HIV infection: perspectives and the future medical care agenda. Aids 31(Suppl 2):S129–S135PubMedCrossRef Guaraldi G, Palella FJ Jr (2017) Clinical implications of aging with HIV infection: perspectives and the future medical care agenda. Aids 31(Suppl 2):S129–S135PubMedCrossRef
go back to reference Gutierrez J, Albuquerque ALA, Falzon L (2017) HIV infection as vascular risk: a systematic review of the literature and meta-analysis. PLoS One 12:e0176686PubMedPubMedCentralCrossRef Gutierrez J, Albuquerque ALA, Falzon L (2017) HIV infection as vascular risk: a systematic review of the literature and meta-analysis. PLoS One 12:e0176686PubMedPubMedCentralCrossRef
go back to reference Gutierrez J, Byrd D, Yin MT, Morgello S (2018) Relationship between brain arterial pathology and neurocognitive performance among individuals with human immunodeficiency virus. Clin Infect Dis 11 Gutierrez J, Byrd D, Yin MT, Morgello S (2018) Relationship between brain arterial pathology and neurocognitive performance among individuals with human immunodeficiency virus. Clin Infect Dis 11
go back to reference Gyaneshwar R, Naidu S, Raban MZ, Naidu S, Linhart C, Morrell S, Tukana I, Taylor R (2016) Absolute cardiovascular risk in a Fiji medical zone. BMC Public Health 16:128PubMedPubMedCentralCrossRef Gyaneshwar R, Naidu S, Raban MZ, Naidu S, Linhart C, Morrell S, Tukana I, Taylor R (2016) Absolute cardiovascular risk in a Fiji medical zone. BMC Public Health 16:128PubMedPubMedCentralCrossRef
go back to reference Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. Aids 25:625–633PubMedCrossRef Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. Aids 25:625–633PubMedCrossRef
go back to reference Hatleberg CI, Lundgren JD, Ryom L (2017) Are we successfully managing cardiovascular disease in people living with HIV? Curr Opin HIV AIDS 12:594–603PubMedCrossRef Hatleberg CI, Lundgren JD, Ryom L (2017) Are we successfully managing cardiovascular disease in people living with HIV? Curr Opin HIV AIDS 12:594–603PubMedCrossRef
go back to reference Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087–2096PubMedPubMedCentralCrossRef Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087–2096PubMedPubMedCentralCrossRef
go back to reference Helman AM, Murphy MP (2016) Vascular cognitive impairment: modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta 1862:975–982PubMedCrossRef Helman AM, Murphy MP (2016) Vascular cognitive impairment: modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta 1862:975–982PubMedCrossRef
go back to reference Holloway CJ, Boccara F (2017) HIV-related cardiovascular disease: closing the gap in mortality. Curr Opin HIV AIDS 12:509–512PubMedCrossRef Holloway CJ, Boccara F (2017) HIV-related cardiovascular disease: closing the gap in mortality. Curr Opin HIV AIDS 12:509–512PubMedCrossRef
go back to reference Horsburgh K, Wardlaw JM, van Agtmael T, Allan SM, Ashford MLJ, Bath PM, Brown R, Berwick J, Cader MZ, Carare RO, Davis JB, Duncombe J, Farr TD, Fowler JH, Goense J, Granata A, Hall CN, Hainsworth AH, Harvey A, Hawkes CA, Joutel A, Kalaria RN, Kehoe PG, Lawrence CB, Lockhart A, Love S, Macleod MR, Macrae IM, Markus HS, McCabe C, McColl BW, Meakin PJ, Miller A, Nedergaard M, O'Sullivan M, Quinn TJ, Rajani R, Saksida LM, Smith C, Smith KJ, Touyz RM, Trueman RC, Wang T, Williams A, Williams SCR, Work LM (2018) Small vessels, dementia and chronic diseases—molecular mechanisms and pathophysiology. Clin Sci (Lond) 132:851–868CrossRef Horsburgh K, Wardlaw JM, van Agtmael T, Allan SM, Ashford MLJ, Bath PM, Brown R, Berwick J, Cader MZ, Carare RO, Davis JB, Duncombe J, Farr TD, Fowler JH, Goense J, Granata A, Hall CN, Hainsworth AH, Harvey A, Hawkes CA, Joutel A, Kalaria RN, Kehoe PG, Lawrence CB, Lockhart A, Love S, Macleod MR, Macrae IM, Markus HS, McCabe C, McColl BW, Meakin PJ, Miller A, Nedergaard M, O'Sullivan M, Quinn TJ, Rajani R, Saksida LM, Smith C, Smith KJ, Touyz RM, Trueman RC, Wang T, Williams A, Williams SCR, Work LM (2018) Small vessels, dementia and chronic diseases—molecular mechanisms and pathophysiology. Clin Sci (Lond) 132:851–868CrossRef
go back to reference Hsue PY, Waters DD (2017) Heart failure in persons living with HIV infection. Curr Opin HIV AIDS 12:534–539PubMedCrossRef Hsue PY, Waters DD (2017) Heart failure in persons living with HIV infection. Curr Opin HIV AIDS 12:534–539PubMedCrossRef
go back to reference Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker LG, Triant VA (2017) The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. BMC Public Health 17:954PubMedPubMedCentralCrossRef Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker LG, Triant VA (2017) The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. BMC Public Health 17:954PubMedPubMedCentralCrossRef
go back to reference Johnson Shen M, Freeman R, Karpiak S, Brennan-Ing M, Seidel L, Siegler EL (2018) The intersectionality of stigmas among key populations of older adults affected by HIV: a thematic analysis. Clin Gerontol 26:1–13 Johnson Shen M, Freeman R, Karpiak S, Brennan-Ing M, Seidel L, Siegler EL (2018) The intersectionality of stigmas among key populations of older adults affected by HIV: a thematic analysis. Clin Gerontol 26:1–13
go back to reference Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T (2018) Cerebrospinal fluid ceruloplasmin, haptoglobin, and vascular endothelial growth factor are associated with neurocognitive impairment in adults with HIV infection. Mol Neurobiol 12:018–1329 Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T (2018) Cerebrospinal fluid ceruloplasmin, haptoglobin, and vascular endothelial growth factor are associated with neurocognitive impairment in adults with HIV infection. Mol Neurobiol 12:018–1329
go back to reference Lagathu C, Cossarizza A, Bereziat V, Nasi M, Capeau J, Pinti M (2017) Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. Aids 31(Suppl 2):S105–S119PubMedCrossRef Lagathu C, Cossarizza A, Bereziat V, Nasi M, Capeau J, Pinti M (2017) Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. Aids 31(Suppl 2):S105–S119PubMedCrossRef
go back to reference Le LT, Spudich SS (2016) HIV-associated neurologic disorders and central nervous system opportunistic infections in HIV. Semin Neurol 36:373–381PubMedCrossRef Le LT, Spudich SS (2016) HIV-associated neurologic disorders and central nervous system opportunistic infections in HIV. Semin Neurol 36:373–381PubMedCrossRef
go back to reference Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N (2018). Higher anti-cytomegalovirus immunoglobulin G concentrations are associated with worse neurocognitive performance during suppressive antiretroviral therapy. Clin Infect Dis 67:770–777PubMedPubMedCentralCrossRef Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N (2018). Higher anti-cytomegalovirus immunoglobulin G concentrations are associated with worse neurocognitive performance during suppressive antiretroviral therapy. Clin Infect Dis 67:770–777PubMedPubMedCentralCrossRef
go back to reference Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G, Lima-Costa MF, Castro-Costa E, Brayne C, Matthews FE, Stephan BC, Lipton RB, Katz MJ, Ritchie K, Scali J, Ancelin ML, Scarmeas N, Yannakoulia M, Dardiotis E, Lam LC, Wong CH, Fung AW, Guaita A, Vaccaro R, Davin A, Kim KW, Han JW, Kim TH, Anstey KJ, Cherbuin N, Butterworth P, Scazufca M, Kumagai S, Chen S, Narazaki K, Ng TP, Gao Q, Reppermund S, Brodaty H, Lobo A, Lopez-Anton R, Santabarbara J, Sachdev PS (2017) Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med 14:e1002261PubMedPubMedCentralCrossRef Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G, Lima-Costa MF, Castro-Costa E, Brayne C, Matthews FE, Stephan BC, Lipton RB, Katz MJ, Ritchie K, Scali J, Ancelin ML, Scarmeas N, Yannakoulia M, Dardiotis E, Lam LC, Wong CH, Fung AW, Guaita A, Vaccaro R, Davin A, Kim KW, Han JW, Kim TH, Anstey KJ, Cherbuin N, Butterworth P, Scazufca M, Kumagai S, Chen S, Narazaki K, Ng TP, Gao Q, Reppermund S, Brodaty H, Lobo A, Lopez-Anton R, Santabarbara J, Sachdev PS (2017) Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med 14:e1002261PubMedPubMedCentralCrossRef
go back to reference Mayeda ER, Tchetgen Tchetgen EJ, Power MC, Weuve J, Jacqmin-Gadda H, Marden JR, Vittinghoff E, Keiding N, Glymour MM (2016) A simulation platform for quantifying survival bias: an application to research on determinants of cognitive decline. Am J Epidemiol 184:378–387PubMedPubMedCentralCrossRef Mayeda ER, Tchetgen Tchetgen EJ, Power MC, Weuve J, Jacqmin-Gadda H, Marden JR, Vittinghoff E, Keiding N, Glymour MM (2016) A simulation platform for quantifying survival bias: an application to research on determinants of cognitive decline. Am J Epidemiol 184:378–387PubMedPubMedCentralCrossRef
go back to reference McCrary AW, Nduka CU, Stranges S, Bloomfield GS (2017) Features of cardiovascular disease in low-income and middle-income countries in adults and children living with HIV. Curr Opin HIV AIDS 12:579–584PubMedCrossRef McCrary AW, Nduka CU, Stranges S, Bloomfield GS (2017) Features of cardiovascular disease in low-income and middle-income countries in adults and children living with HIV. Curr Opin HIV AIDS 12:579–584PubMedCrossRef
go back to reference McHutchison CA, Backhouse EV, Cvoro V, Shenkin SD, Wardlaw JM (2017) Education, socioeconomic status, and intelligence in childhood and stroke risk in later life: a meta-analysis. Epidemiology 28:608–618PubMedCrossRef McHutchison CA, Backhouse EV, Cvoro V, Shenkin SD, Wardlaw JM (2017) Education, socioeconomic status, and intelligence in childhood and stroke risk in later life: a meta-analysis. Epidemiology 28:608–618PubMedCrossRef
go back to reference Milanini B, Valcour V (2017) Differentiating HIV-associated neurocognitive disorders from Alzheimer’s disease: an emerging issue in geriatric NeuroHIV. Curr HIV/AIDS Rep 14:123–132PubMedPubMedCentralCrossRef Milanini B, Valcour V (2017) Differentiating HIV-associated neurocognitive disorders from Alzheimer’s disease: an emerging issue in geriatric NeuroHIV. Curr HIV/AIDS Rep 14:123–132PubMedPubMedCentralCrossRef
go back to reference Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D (2018) Silent cerebral small-vessel disease is twice as prevalent in middle-aged individuals with well-controlled, combination antiretroviral therapy-treated human immunodeficiency virus (HIV) than in HIV-uninfected individuals. Clin Infect Dis 66:1762–1769PubMedCrossRef Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D (2018) Silent cerebral small-vessel disease is twice as prevalent in middle-aged individuals with well-controlled, combination antiretroviral therapy-treated human immunodeficiency virus (HIV) than in HIV-uninfected individuals. Clin Infect Dis 66:1762–1769PubMedCrossRef
go back to reference Nedelcovych MT, Manning AA, Semenova S, Gamaldo C, Haughey NJ, Slusher BS (2017) The psychiatric impact of HIV. ACS Chem Neurosci 8:1432–1434PubMedCrossRef Nedelcovych MT, Manning AA, Semenova S, Gamaldo C, Haughey NJ, Slusher BS (2017) The psychiatric impact of HIV. ACS Chem Neurosci 8:1432–1434PubMedCrossRef
go back to reference Panza F, Solfrizzi V, Logroscino G, Maggi S, Santamato A, Seripa D, Pilotto A (2012) Current epidemiological approaches to the metabolic-cognitive syndrome. J Alzheimers Dis 30(Suppl 2):S31–S75PubMedCrossRef Panza F, Solfrizzi V, Logroscino G, Maggi S, Santamato A, Seripa D, Pilotto A (2012) Current epidemiological approaches to the metabolic-cognitive syndrome. J Alzheimers Dis 30(Suppl 2):S31–S75PubMedCrossRef
go back to reference Paratz ED, Cunningham NJ, MacIsaac AI (2016) The cardiac complications of methamphetamines. Heart Lung Circ 25:325–332PubMedCrossRef Paratz ED, Cunningham NJ, MacIsaac AI (2016) The cardiac complications of methamphetamines. Heart Lung Circ 25:325–332PubMedCrossRef
go back to reference Patel S, Parikh NU, Aalinkeel R, Reynolds JL, Dmello R, Schwartz SA, Mahajan SD (2018) United States National Trends in mortality, length of stay (LOS) and associated costs of cognitive impairment in HIV population from 2005 to 2014. AIDS Behav 22:3198–3208PubMedCrossRef Patel S, Parikh NU, Aalinkeel R, Reynolds JL, Dmello R, Schwartz SA, Mahajan SD (2018) United States National Trends in mortality, length of stay (LOS) and associated costs of cognitive impairment in HIV population from 2005 to 2014. AIDS Behav 22:3198–3208PubMedCrossRef
go back to reference Peng SL, Chen X, Li Y, Rodrigue KM, Park DC, Lu H (2018) Age-related changes in cerebrovascular reactivity and their relationship to cognition: a four-year longitudinal study. Neuroimage 174:257–262PubMedCrossRef Peng SL, Chen X, Li Y, Rodrigue KM, Park DC, Lu H (2018) Age-related changes in cerebrovascular reactivity and their relationship to cognition: a four-year longitudinal study. Neuroimage 174:257–262PubMedCrossRef
go back to reference Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El-Sadr W, d'Arminio Monforte A, Phillips AN, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren JD, Law MG (2014) Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. HIV Med 15:595–603PubMed Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El-Sadr W, d'Arminio Monforte A, Phillips AN, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren JD, Law MG (2014) Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. HIV Med 15:595–603PubMed
go back to reference Pfefferbaum A, Zahr NM, Sassoon SA, Kwon D, Pohl KM, Sullivan EV (2018) Accelerated and premature aging characterizing regional cortical volume loss in human immunodeficiency virus infection: contributions from alcohol, substance use, and hepatitis C coinfection. Biol Psychiatry Cogn Neurosci Neuroimaging 3:844–859PubMedPubMedCentralCrossRef Pfefferbaum A, Zahr NM, Sassoon SA, Kwon D, Pohl KM, Sullivan EV (2018) Accelerated and premature aging characterizing regional cortical volume loss in human immunodeficiency virus infection: contributions from alcohol, substance use, and hepatitis C coinfection. Biol Psychiatry Cogn Neurosci Neuroimaging 3:844–859PubMedPubMedCentralCrossRef
go back to reference Rajasuriar R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, McStea M, Lee ECY, Wong PL, Azwa I, Syed Omar SF, Lai PSM, Ponampalavanar S, Crowe SM, Lewin SR, Kamaruzzaman SB, Kamarulzaman A (2017) Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. Aids 31:1393–1403PubMedCrossRef Rajasuriar R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, McStea M, Lee ECY, Wong PL, Azwa I, Syed Omar SF, Lai PSM, Ponampalavanar S, Crowe SM, Lewin SR, Kamaruzzaman SB, Kamarulzaman A (2017) Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. Aids 31:1393–1403PubMedCrossRef
go back to reference Raposeiras-Roubin S, Abu-Assi E, Iniguez-Romo A (2017) Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV. Curr Opin HIV AIDS 12:523–527PubMedCrossRef Raposeiras-Roubin S, Abu-Assi E, Iniguez-Romo A (2017) Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV. Curr Opin HIV AIDS 12:523–527PubMedCrossRef
go back to reference Rasmussen LD, Engsig FN, Christensen H, Gerstoft J, Kronborg G, Pedersen C, Obel N (2011) Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. Aids 25:1637–1646PubMedCrossRef Rasmussen LD, Engsig FN, Christensen H, Gerstoft J, Kronborg G, Pedersen C, Obel N (2011) Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. Aids 25:1637–1646PubMedCrossRef
go back to reference Rasmussen LD, May MT, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Obel N (2015) Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. Lancet HIV 2:e288–e298PubMedCrossRef Rasmussen LD, May MT, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Obel N (2015) Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. Lancet HIV 2:e288–e298PubMedCrossRef
go back to reference Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG (2017) Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology 89:1594–1603PubMedPubMedCentralCrossRef Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG (2017) Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology 89:1594–1603PubMedPubMedCentralCrossRef
go back to reference Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P (2014) Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 59:1787–1797PubMedCrossRef Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P (2014) Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 59:1787–1797PubMedCrossRef
go back to reference Schwartz M, Baruch K (2014) Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation. J Autoimmun 54:8–14PubMedCrossRef Schwartz M, Baruch K (2014) Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation. J Autoimmun 54:8–14PubMedCrossRef
go back to reference Sico JJ, Chang CC, So-Armah K, Justice AC, Hylek E, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Bidwell Goetz M, Butt AA, Rodriguez-Barradas MC, Gibert C, Leaf D, Brown ST, Samet J, Kazis L, Bryant K, Freiberg MS (2015) HIV status and the risk of ischemic stroke among men. Neurology 84:1933–1940PubMedPubMedCentralCrossRef Sico JJ, Chang CC, So-Armah K, Justice AC, Hylek E, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Bidwell Goetz M, Butt AA, Rodriguez-Barradas MC, Gibert C, Leaf D, Brown ST, Samet J, Kazis L, Bryant K, Freiberg MS (2015) HIV status and the risk of ischemic stroke among men. Neurology 84:1933–1940PubMedPubMedCentralCrossRef
go back to reference Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG (2018) Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement 14:280–292PubMedCrossRef Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG (2018) Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement 14:280–292PubMedCrossRef
go back to reference Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG (2017) The vascular impairment of cognition classification consensus study. Alzheimers Dement 13:624–633PubMedCrossRef Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG (2017) The vascular impairment of cognition classification consensus study. Alzheimers Dement 13:624–633PubMedCrossRef
go back to reference Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, de Wolf F, Hallett TB (2015) Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 15:810–818PubMedPubMedCentralCrossRef Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, de Wolf F, Hallett TB (2015) Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 15:810–818PubMedPubMedCentralCrossRef
go back to reference Stone L, Looby SE, Zanni MV (2017) Cardiovascular disease risk among women living with HIV in North America and Europe. Curr Opin HIV AIDS 12:585–593PubMedPubMedCentralCrossRef Stone L, Looby SE, Zanni MV (2017) Cardiovascular disease risk among women living with HIV in North America and Europe. Curr Opin HIV AIDS 12:585–593PubMedPubMedCentralCrossRef
go back to reference Stover J, Brown T, Puckett R, Peerapatanapokin W (2017) Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators. Aids 31(Suppl 1):S5–S11PubMedCrossRef Stover J, Brown T, Puckett R, Peerapatanapokin W (2017) Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators. Aids 31(Suppl 1):S5–S11PubMedCrossRef
go back to reference Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB (2017) Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. Aids 31:847–856PubMedCrossRef Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB (2017) Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. Aids 31:847–856PubMedCrossRef
go back to reference Tang H, Mao Y, Tang W, Han J, Xu J, Li J (2018) Late for testing, early for antiretroviral therapy, less likely to die: results from a large HIV cohort study in China, 2006-2014. BMC Infect Dis 18:272 Tang H, Mao Y, Tang W, Han J, Xu J, Li J (2018) Late for testing, early for antiretroviral therapy, less likely to die: results from a large HIV cohort study in China, 2006-2014. BMC Infect Dis 18:272
go back to reference Terpstra AR, Worthington C, Ibanez-Carrasco F, O'Brien KK, Yamamoto A, Chan Carusone S, Baltzer Turje R, McDougall P, Granger W, Thompson V, DeSousa M, Creal L, Rae A, Medina C, Morley E, Rourke SB (2018) “I’m just forgetting and I don’t know why”: exploring how people living with HIV-associated neurocognitive disorder view, manage, and obtain support for their cognitive difficulties. Qual Health Res 28:859–872PubMedCrossRef Terpstra AR, Worthington C, Ibanez-Carrasco F, O'Brien KK, Yamamoto A, Chan Carusone S, Baltzer Turje R, McDougall P, Granger W, Thompson V, DeSousa M, Creal L, Rae A, Medina C, Morley E, Rourke SB (2018) “I’m just forgetting and I don’t know why”: exploring how people living with HIV-associated neurocognitive disorder view, manage, and obtain support for their cognitive difficulties. Qual Health Res 28:859–872PubMedCrossRef
go back to reference The Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372:293–299PubMedCentralCrossRef The Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372:293–299PubMedCentralCrossRef
go back to reference Ulfhammer G, Eden A, Mellgren A, Fuchs D, Zetterberg H, Hagberg L, Nilsson S, Yilmaz A, Gisslen M (2018) Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment. Aids 32:2171–2178PubMedCrossRef Ulfhammer G, Eden A, Mellgren A, Fuchs D, Zetterberg H, Hagberg L, Nilsson S, Yilmaz A, Gisslen M (2018) Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment. Aids 32:2171–2178PubMedCrossRef
go back to reference Underwood J, De Francesco D, Leech R, Sabin CA, Winston A (2018) Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment. PLoS One 13:e0194760PubMedPubMedCentralCrossRef Underwood J, De Francesco D, Leech R, Sabin CA, Winston A (2018) Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment. PLoS One 13:e0194760PubMedPubMedCentralCrossRef
go back to reference van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH, Scheltens P (2018) Vascular cognitive impairment. Nat Rev Dis Primers 4:18003PubMedCrossRef van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH, Scheltens P (2018) Vascular cognitive impairment. Nat Rev Dis Primers 4:18003PubMedCrossRef
go back to reference van Zoest RA, van den Born BH, Reiss P (2017) Hypertension in people living with HIV. Curr Opin HIV AIDS 12:513–522PubMedCrossRef van Zoest RA, van den Born BH, Reiss P (2017) Hypertension in people living with HIV. Curr Opin HIV AIDS 12:513–522PubMedCrossRef
go back to reference Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY, Eron JJ (2013) Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retrovir 29:1068–1074PubMedCrossRefPubMedCentral Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY, Eron JJ (2013) Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retrovir 29:1068–1074PubMedCrossRefPubMedCentral
go back to reference Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 75:1150–1158PubMedPubMedCentralCrossRef Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 75:1150–1158PubMedPubMedCentralCrossRef
go back to reference Weuve J, Proust-Lima C, Power MC, Gross AL, Hofer SM, Thiébaut R, Chêne G, Glymour MM, Dufouil C (2015) Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. Alzheimers Dement 11:1098–1109PubMedPubMedCentralCrossRef Weuve J, Proust-Lima C, Power MC, Gross AL, Hofer SM, Thiébaut R, Chêne G, Glymour MM, Dufouil C (2015) Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. Alzheimers Dement 11:1098–1109PubMedPubMedCentralCrossRef
go back to reference Wiemers PD, Marney L, Yadav S, Tam R, Fraser JF (2018) An overview of indigenous Australian disadvantage in terms of ischaemic heart disease. Heart Lung Circ 27:1274–1284PubMedCrossRef Wiemers PD, Marney L, Yadav S, Tam R, Fraser JF (2018) An overview of indigenous Australian disadvantage in terms of ischaemic heart disease. Heart Lung Circ 27:1274–1284PubMedCrossRef
go back to reference Wright ST, Petoumenos K, Boyd M, Carr A, Downing S, O'Connor CC, Grotowski M, Law MG (2013) Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience. HIV Med 14:208–216PubMedCrossRef Wright ST, Petoumenos K, Boyd M, Carr A, Downing S, O'Connor CC, Grotowski M, Law MG (2013) Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience. HIV Med 14:208–216PubMedCrossRef
go back to reference Xia X, Jiang Q, McDermott J, Han JDJ (2018) Aging and Alzheimer’s disease: comparison and associations from molecular to system level. Aging Cell 17:1474–9726CrossRef Xia X, Jiang Q, McDermott J, Han JDJ (2018) Aging and Alzheimer’s disease: comparison and associations from molecular to system level. Aging Cell 17:1474–9726CrossRef
go back to reference Xu S, Vucic EA, Shaipanich T, Lam S, Lam W, Montaner JS, Sin DD, Paul Man SF, Leung JM (2018) Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV). Respir Res 19:117PubMedPubMedCentralCrossRef Xu S, Vucic EA, Shaipanich T, Lam S, Lam W, Montaner JS, Sin DD, Paul Man SF, Leung JM (2018) Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV). Respir Res 19:117PubMedPubMedCentralCrossRef
go back to reference Zwanenburg JJM, van Osch MJP (2017) Targeting cerebral small vessel disease with MRI. Stroke 48:3175–3182PubMedCrossRef Zwanenburg JJM, van Osch MJP (2017) Targeting cerebral small vessel disease with MRI. Stroke 48:3175–3182PubMedCrossRef
Metadata
Title
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm
Authors
Lucette A. Cysique
Bruce J. Brew
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Journal of NeuroVirology / Issue 5/2019
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-018-0706-5

Other articles of this Issue 5/2019

Journal of NeuroVirology 5/2019 Go to the issue